Canada's EndoCeutics Lowers IPO Price to $7-$9
5/10/2007 8:56:41 AM
WASHINGTON, May 9 (Reuters) - Canada's EndoCeutics Inc., a pharmaceutical firm, lowered the price of its planned initial public offering to between $7 and $9 per share from between $11-$13 each.
>>> Discuss This Story
comments powered by